Senator inquires about FDA approval of ReGen knee implant

03/10/2009 | Wall Street Journal (free content), The

Sen. Chuck Grassley, R-Iowa, sent letters to ReGen Biologics and the FDA requesting information related to the agency's approval last fall of a knee implant made by ReGen. Grassley's inquiry comes after a report appeared in The Wall Street Journal on Friday about a controversy surrounding the approval.

View Full Article in:

Wall Street Journal (free content), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN